Teens often spend hours daily watching videos online, but parents should consider how the content affects their well-being ...

Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved STOBOCLO® (CT-P41, denosumab-bmwo) ...

Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company"), a global biopharmaceutical company, and mAbxience ("mAbxience") today announced that the U.S. Food and Drug Administration (FDA) has accepted ...

Amneal Pharmaceuticals (AMRX) “announced that the FDA has accepted for review its Biologics Licensing Application for two proposed denosumab ...

February brought policy updates and several biosimilar approvals, including the first FDA approval for an insulin aspart biosimilar.

Women with osteoporosis have at least a 50% chance of reaching their target bone mineral density at 3 years if they have a ...

Women's Health Therapeutics Market Rising Awareness and Government Initiatives Drive Growth AUSTIN, TX, UNITED STATES, February 28, 202 ...

In this article, we explore how aging impacts the musculoskeletal system and share expert-backed prevention tips to help you ...

Osteoporosis, often called a silent disease, weakens bones and increases the risk of fractures, making it a leading cause of ...

The FDA has approved the BLA for Ospomyv™ and Xbryk™, biosimilars to Prolia (denosumab) and Xgeva (denosumab), respectively.

"Woman," "elderly," and "disabled" were among a list of banned words reportedly circulating within the FDA, which the White ...

Researchers explored how Pluvicto is used in the community and academic settings and when given by oncologists or urologists.